On November 17, 2026, Handelsblatt reported that Anthropic had signaled to prospective investors that it expected its IPO price to reach the top of its initial $70–$78-per-share range or go higher. The report, based on people familiar with the matter, described an expectation, not a set offer price. Coverage scheduled Nasdaq trading under the ticker ANT for November 19.
What Anthropic reportedly indicated about its IPO price
The reported starting range was $70 to $78 a share. Handelsblatt said Anthropic was signaling a price of $78 or more; an Expansión report relayed a possibility above $80, attributing it to The Wall Street Journal. These were reported expectations, not the same measure as an analyst’s estimate of a share’s value.
The articles placed price-setting on November 18 and described a planned listing on the Nasdaq Global Select Market. For background on the company’s filing, see NeoTeo’s earlier report on Anthropic’s S-1.
A proposed IPO price is one term of a share sale; it does not, by itself, settle what the company is worth.
What the proposed share sale included
The described base offer totaled 825 million shares: 801.35 million Class A shares from Anthropic and 23.65 million from existing shareholders, according to El Periódico. At $78 per share, the gross value of those 825 million shares would be $64.35 billion.
That offering value is different from the roughly $1.4 trillion fully diluted valuation reported at the same $78 share price. A fully diluted valuation counts shares and other securities that could become shares, rather than just the shares sold in the public offering. The reported combined-proceeds estimate of $90.4 billion also included a separate private placement of up to $26 billion; it was not the value of the public share sale alone.
How Morningstar’s valuation scenarios compare
Morningstar’s analyst model put fair value at $92 per share in its base case, with a $25 bear case and a $188 bull case. The estimates span a wide range beside the reported $70–$78 offer range, but they are model valuations, not IPO terms or market prices. Morningstar’s analysis also forecast 47% revenue growth over 2027–2031.
For broader coverage of finance and investing beyond this deal, NTV88 is a related publication.